search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
21 Particle Characterisation Characterising Complex Polymers in Challenging Solvents


The AYE Combo from Testa Analytical is a unique GPC/SEC detector designed to have a high performance refractometer as an integral part of a viscometer, allowing both concentration and viscosity to be measured at exactly the same time on the very same sample segment.


As a consequence the AYE Combo Refractometer/Viscometer detector enables a much more accurate determination of molecular parameters and is particular suitable for applications focused on determining the structure and branching of complex polymers.


GPC/SEC is widely acknowledged as a primary analytical technique for characterising polymers. The latest generation of complex high performance polymers however, add a notable degree of complication by requiring the use of ‘challenging’ solvents such as DMSO, DMF and HFIP to dissolve them. Unfortunately, most GPC/SEC systems require frequent maintenance when operating with these solvents.


Drawing upon pressure transducers made out the most stable alloy available combined with highest grade 316T capillary tubing The AYE Combo detector is gaining rapid recognition as the GPC/SEC detector of choice for characterising complex polymers in challenging solvents.


More information online: ilmt.co/PL/ZJrX 52452pr@reply-direct.com


A New Dimension in Particle Analysis


Characterising Virus and Virus-Like Particles


Postnova Analytics reports how its latest generation of Asymmetrical Flow Field Flow Fractionation (AF4) systems are providing labs worldwide with a uniquely powerful technique to characterise and quantitate virus and virus-like particles.


Virus and virus-like particles are widely used in the healthcare industry for vaccination via immune response stimulation. Because these particles are to be injected into patients there is a critical requirement for a technique that allows detection and separation of the monomeric, oligomeric and aggregated species in a typical formulation.


While Size Exclusion Chromatography (SEC) has been a traditional analytical technique used for this application it has significant limitations relating to the size exclusion limit of the separation column that restricts the upper molar mass and particle size range that can be measured.


By comparison, Asymmetrical Flow Field Flow Fractionation (AF4) is an advanced separation technique that can address the problems associated with SEC. In AF4, an open, unpacked separation channel is used in place of a packed column.


The Microtrac MRB SYNC Analyzer provides traditional users of laser diffraction technology with exciting new capabilities to characterise their materials. The proven tri-laser technology provides accurate and repeatable laser diffraction information from light detected over 163 degrees of angular scatter. When combined with state-of-the-art camera technology capturing images of the particle stream at the same time, the SYNC offers not only size data but significantly more information about the shape of the materials and the quality of the dispersion.


The patented Synchronous measurement technology of the SYNC allows users to make both a laser diffraction measurement and an image analysis measurement on a single sample, in the same sample cell at the same time: One sample, one optical bench, one flow path, one sample cell, one integrated GUI, one analysis.


This makes the SYNC ideally suited for both routine QC and research applications; it provides valuable information to researchers as they develop new materials and processes. The powerful software interface offers both particle size distribution information as well as a multitude of morphological parameters. The patented BLEND routine allows users to examine materials over a wide size range from 0.01 microns to 4000 microns


More information online: ilmt.co/PL/Bd9R 52569pr@reply-direct.com


The Spotlight could be on you!


Send your Press Releases to Gwyneth Astles gwyneth@intlabmate.com


Low-fi eld NMR Instrument for Complex Nanoparticle


Suspensions Characterisation Mageleka Inc is a scientifi c instrumentation company focused on the analysis and characterisation of complex, multi-component nanoparticle suspensions. The company was founded by a group of entrepreneurs with many years experience in industry, academe and in the development of analytical instrumentation. The new Magnometer XRS, is based on low-fi eld nuclear magnetic resonance and is now available.


The technique can characterise dispersions made with any nanoparticle and is sensitive to both surface and solution chemical environments and adsorbing additives such as polymers and surfactants: it is ideal for quality control. Applications include batch-to-batch reproducibility in a manufacturing environment and raw materials control. The technique is simple to use and does not require sample preparation with most measurements performed in under 2 minutes. Current customers include


catalyst companies, pharmaceutical and personal health care providers. More information online: ilmt.co/PL/wZvD


52276pr@reply-direct.com


The absence of a stationary phase in AF4 systems results in the ability to use a wider range of solvents, elimination of SEC shear force and matrix interaction effects as well as the ability to separate particles over a very wide size range, from 1 nm up to above 1 µm. These capabilities enable AF4 to provide a complete picture of virus and virus-like particles including monomer content, insoluble and soluble aggregates, as well as the subvisible particle fraction.


More information online: ilmt.co/PL/Q0QP 52453pr@reply-direct.com


ADVERTORIAL


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52